Events Partner Content SMi's 9th Annual Orphan Drugs & Rare Diseases Conference Orphan Drugs & Rare Diseases
Partner Content Partner Content Registration Opens for SMi’s 9th Annual Orphan Drugs & Rare ... Registration Opens for Orphan Drugs
R&D Deep Dive: R&D Innovation In this issue of Deep Dive we look at innovation in pharma R&D, asking how can pharmaceutical companies change up the development model with new strategies and technologies to cut waste
Partner Content Partner Content Preliminary Attendee List Released for Orphan Drugs & Rare D... Attendees Released for Orphan Drugs & Rare Diseases
Partner Content Partner Content Only 4 Weeks Until Orphan Drugs & Rare Diseases 2018 Pharma Giants Unite to Improve Rare Disease Treatment
Partner Content Partner Content Carina Schey, University of Groningen, Orphan Drugs & Ra... Chair Invitation to Orphan Drugs & Rare Diseases 2018
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.